Cardiology Solutions

We believe hospitals should have complete choice of suppliers and be able to access the best-in-class solutions you need to evolve your cardiology strategy.

As your vendor agnostic and technology agnostic partner we can make it happen. Our cardiology managed services allow you to plan and implement your preferred solutions – including consumables – at the pace you choose.

We are currently looking for pilot sites for our new and innovative model for Cardiology Managed Services. Please get in touch with us on info@genmed.eu or 0345 450 2204 for more information.

Service benefits

  • Complete end-to-end solution
  • Full supplier choice
  • Equipment funding access – no requirement for a customer to use capital resources as we can provide access to third party funding allowing the ability to plan for the refresh of ageing equipment
  • Purchase of legacy on balance sheet equipment creating immediate costs savings
  • Reduction in administrative burden
  • Off-balance sheet and IFRS16/IFRICS4 friendly contracts
  • Full risk transfer
  • Turnkey capabilities and access to funding for buildings
  • Easy engagement – Genmed is on several frameworks which facilitates procurement compliance and speed of contracting
frameworks

Frameworks

Genmed is on several frameworks for the NHS and wider public sector to access our solutions. This helps in choosing the fastest route to the support you require, and the confidence that you’re working with an approved and experienced provider.

Read more

Contact us

What we can do for you...

Genmed offers us the flexibility of different purchase routes and funding options. They work at pace and their support helps us to deliver our unique service and maintain our position as a centre of excellence. This type of partnership is something which is rare in the NHS.
Mary Richardson, Director, SWLEOC
The new way of working with Genmed allows staff more time to concentrate on their clinical work, which is very helpful for workflow in the laboratory. As the health service recovers from COVID-19 and the number of outpatient appointments increase, having greater capacity to deal with increased throughput of samples is essential
Saskia Neuert, Senior Genetic Technologist, Cambridge University Hospitals NHS Foundation Trust – East Genomics Laboratory Hub